UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Open-label, phase 2, multicenter study of lasofoxifene (LAS) combined with abemaciclib (Abema) for treating pre- and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and an ESR1 mutation after progression on prior therapies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1022-1022

2022

Link zum Volltext

Verfügbarkeit prüfen

Arimidex : A potent and selective fourth-generation aromatase inhibitor

Breast cancer research and treatment, 1994, Vol.30 (1), p.103-111

1994

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT-09-01: An open-label, multicenter study evaluating the safety of lasofoxifene in combination with abemaciclib for the treatment of pre and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and have an ESR1 mutation

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-09-01-OT-09-01

2021

Link zum Volltext

Verfügbarkeit prüfen

Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1 -mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1057-1057

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-02: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-05-02

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-05-04

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.7097-7097

2013

Link zum Volltext

Verfügbarkeit prüfen

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol

Blood, 2012-11, Vol.120 (21), p.2568-2568

2012

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli-Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Blood, 2013-11, Vol.122 (21), p.3904-3904

2013

Link zum Volltext

Verfügbarkeit prüfen

The evolution of legislation to regulate pediatric clinical trials : Present and continuing challenges: Challenges in pediatric drug delivery: the case of vaccines

Advanced drug delivery reviews, 2006, Vol.58 (1), p.106-115

2006

Link zum Volltext

Verfügbarkeit prüfen

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Blood, 2010-11, Vol.116 (21), p.2134-2134

2010

Link zum Volltext

Verfügbarkeit prüfen

Home care providers' perceptions of shared decision‐making with older clients (and their caregivers): A cross‐sectional study

Nursing & health sciences, 2022-06, Vol.24 (2), p.487-498

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Decision Regret among Caregivers of Older Canadians Receiving Home Care: A Cross-Sectional Online Survey

MDM policy & practice, 2022-07, Vol.7 (2), p.238146832211163-23814683221116304

2022

Link zum Volltext

Verfügbarkeit prüfen

Arènes du débat public

Questions de communication (Nancy), 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(3)
Cancer Research
(3)
Journal Of Clinical Oncology
(3)
Advanced Drug Delivery Reviews
(1)
Breast Cancer Research And Treatment
(1)
Mdm Policy & Practice
(1)
Nursing & Health Sciences
(1)
Questions De Communication
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Open-label, phase 2, multicenter study of lasofoxifene (LAS) combined with abemaciclib (Abema) for treating pre- and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and an ESR1 mutation after progression on prior therapies

Arimidex : A potent and selective fourth-generation aromatase inhibitor

Abstract OT-09-01: An open-label, multicenter study evaluating the safety of lasofoxifene in combination with abemaciclib for the treatment of pre and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and have an ESR1 mutation

Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1 -mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update

Abstract P5-05-02: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study

Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study

Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli-Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

The evolution of legislation to regulate pediatric clinical trials : Present and continuing challenges: Challenges in pediatric drug delivery: the case of vaccines

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Home care providers' perceptions of shared decision‐making with older clients (and their caregivers): A cross‐sectional study

Predictors of Decision Regret among Caregivers of Older Canadians Receiving Home Care: A Cross-Sectional Online Survey

Arènes du débat public

Aktive Filter

Suchergebnisse filtern